BioReliance (Merck)
Glasgow, UK · Rockville, MD
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
81.5
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
✓ MHRA GMP (8)
Quick Facts: BioReliance (Merck)
- Signal Score
- 81.5/100 (as of 2026-04-02)
- Quality Compliance
- 99.8/100
- Headquarters
- Glasgow, UK · Rockville, MD
- Modalities
- AAV, Lentiviral, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
99.8
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-11-22)
MHRA GMP Certificates8 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Merck KGaA
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Merck KGaA
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Glasgow, UK, Rockville, MD
Source: SEC EDGAR, press monitoring, company profiles
2 manufacturing sites
2 manufacturing sites
FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-22 | Rockville, Maryland | Vaccines and Allergenic Products | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
MHRA GMP Compliance 8 certificates
2025-05
2025-05
2025-03
2025-03
2025-02
2025-02
2013-07
2012-07
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK GMP 22774 Insp GMP/IMP 22774/31007-0023 [H] | BIORELIANCE LIMITED | STIRLING FK9 4NF | 2025-05-02 | COMPLIANT |
| UK GMP 22774 Insp GMP/IMP 22774/31007-0023 [V] | BIORELIANCE LIMITED | STIRLING FK9 4NF | 2025-05-02 | COMPLIANT |
| UK GMP 22774 Insp GMP/IMP 22774/2062763-0012 [H] | BIORELIANCE LIMITED | PENICUIK EH26 0PZ | 2025-03-19 | COMPLIANT |
| UK GMP 22774 Insp GMP/IMP 22774/2062763-0012 [V] | BIORELIANCE LIMITED | PENICUIK EH26 0PZ | 2025-03-19 | COMPLIANT |
| UK MIA 22774 Insp GMP 13987/4473-0031[H] | BIORELIANCE LIMITED | GLASGOW G20 0XA | 2025-02-13 | COMPLIANT |
| UK API 22774 Insp GMP 13987/4473-0031 | BIORELIANCE LIMITED | GLASGOW G20 0XA | 2025-02-13 | COMPLIANT |
| UK GMP 18729 Insp GMP 18729/376405-0002[H] | BIORELIANCE CORPORATION | 20850-3349 | 2013-07-15 | COMPLIANT |
| UK MIA 22774 Insp GMP/IMP 22774/31007-0012[H] | BIORELIANCE LIMITED | STIRLING FK9 4NF | 2012-07-25 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Apr 05, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
ProBioGen
Berlin, DE
Signal Score: 78.1
AAV, Lentiviral, Biologics
Bionova Scientific
Fremont, CA
Signal Score: 59.0
AAV, Lentiviral, Biologics
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid